Found: 14
Select item for more details and to access through your institution.
Evolution of the Antigenic Landscape in Children and Young Adults with COVID-19 and MIS-C.
- Published in:
- Vaccines, 2024, v. 12, n. 6, p. 638, doi. 10.3390/vaccines12060638
- By:
- Publication type:
- Article
Monoclonal antibodies targeting sites in respiratory syncytial virus attachment G protein provide protection against RSV-A and RSV-B in mice.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-47146-2
- By:
- Publication type:
- Article
Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43152-y
- By:
- Publication type:
- Article
Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron and Other Variants in Serum From Children With Vaccination-Induced Myocarditis.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 9, p. 1645, doi. 10.1093/cid/ciac323
- By:
- Publication type:
- Article
Increased Antibody Avidity and Cross-Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Variants by Hyperimmunized Transchromosomic Bovine-Derived Human Immunoglobulins for Treatment of Coronavirus Disease 2019.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 4, p. 655, doi. 10.1093/infdis/jiac031
- By:
- Publication type:
- Article
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30649-1
- By:
- Publication type:
- Article
Author Correction: Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32298-w
- By:
- Publication type:
- Article
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-30649-1
- By:
- Publication type:
- Article
Insect cell expression and purification of recombinant SARS‐COV‐2 spike proteins that demonstrate ACE2 binding.
- Published in:
- Protein Science: A Publication of the Protein Society, 2022, v. 31, n. 5, p. 1, doi. 10.1002/pro.4300
- By:
- Publication type:
- Article
Impact of Convalescent Plasma Therapy on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Profile in Coronavirus Disease 2019 (COVID-19) Patients.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 2, p. 327, doi. 10.1093/cid/ciab317
- By:
- Publication type:
- Article
Immune responses and therapeutic challenges in paediatric patients with new‐onset acute myeloid leukaemia and concomitant COVID‐19.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 3, p. 549, doi. 10.1111/bjh.17517
- By:
- Publication type:
- Article
Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21463-2
- By:
- Publication type:
- Article
Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 550, p. 1, doi. 10.1126/scitranslmed.abc3539
- By:
- Publication type:
- Article